30 Jun 2020 --- Direct-to-consumer custom probiotics start-up Sun Genomics has raised US$8.65 million in its Series A funding. The round was led by Pangaea Ventures with additional investments from Danone Manifesto Ventures, SOSV, Human Longevity and Nascita Ventures. The funding will support further growth in the personalized probiotics market, advance scientific publications and scale the delivery of the start-up’s range of gut probiotics solutions. The company seeks to build “the world’s largest longitudinal data set” to boost its probiotics customization capabilities.
